Total Payments
$9,566
2024 Payments
$1,984
Companies
44
Transactions
569
Medicare Patients
13,235
Medicare Billing
$3.4M
Payment Breakdown by Category
Food & Beverage$9,093 (95.1%)
Education$473.07 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,093 | 563 | 95.1% |
| Education | $473.07 | 6 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,216 | 72 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,021 | 74 | $0 (2024) |
| ABBVIE INC. | $972.16 | 73 | $0 (2024) |
| LEO Pharma Inc. | $717.97 | 64 | $0 (2024) |
| Galderma Laboratories, L.P. | $648.83 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $575.37 | 26 | $0 (2024) |
| GENZYME CORPORATION | $415.11 | 17 | $0 (2024) |
| PFIZER INC. | $391.83 | 24 | $0 (2024) |
| Allergan, Inc. | $348.35 | 12 | $0 (2022) |
| Lilly USA, LLC | $319.79 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,984 | 91 | Regeneron Healthcare Solutions, Inc. ($250.98) |
| 2023 | $1,642 | 88 | Janssen Biotech, Inc. ($356.57) |
| 2022 | $1,541 | 86 | Janssen Biotech, Inc. ($297.27) |
| 2021 | $1,266 | 83 | Novartis Pharmaceuticals Corporation ($211.11) |
| 2020 | $733.35 | 46 | VYNE Pharmaceuticals Inc. ($113.57) |
| 2019 | $582.66 | 45 | Janssen Biotech, Inc. ($146.24) |
| 2018 | $895.99 | 49 | Allergan Inc. ($199.13) |
| 2017 | $922.38 | 81 | Aqua Pharmaceuticals ($207.58) |
All Payment Transactions
569 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $24.36 | General |
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $110.70 | General |
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Immunology | ||||||
| 10/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Immunology | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,315 | 6,477 | $2.0M | $829,313 |
| 2022 | 32 | 3,340 | 6,713 | $2.0M | $850,447 |
| 2021 | 32 | 3,561 | 7,948 | $2.2M | $943,199 |
| 2020 | 32 | 3,019 | 6,379 | $1.9M | $790,889 |
Total Patients
13,235
Total Services
27,517
Medicare Billing
$3.4M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 379 | 445 | $465,692 | $170,222 | 36.6% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Facility | 2023 | 196 | 209 | $360,734 | $149,184 | 41.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 259 | 422 | $269,236 | $139,522 | 51.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 105 | 123 | $121,155 | $47,236 | 39.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 195 | 356 | $93,159 | $45,987 | 49.4% |
| 14302 | Repair of wound by transferring skin, each additional 30.0 sq cm | Facility | 2023 | 97 | 191 | $66,850 | $34,409 | 51.5% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Facility | 2023 | 53 | 54 | $78,030 | $33,511 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 388 | 509 | $71,024 | $33,379 | 47.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 252 | 337 | $58,829 | $28,585 | 48.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 51 | 78 | $47,580 | $24,770 | 52.1% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Facility | 2023 | 29 | 30 | $46,890 | $18,901 | 40.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 312 | 463 | $48,727 | $17,068 | 35.0% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Facility | 2023 | 21 | 21 | $32,655 | $14,017 | 42.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 268 | 2,410 | $24,245 | $12,183 | 50.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 168 | 187 | $29,272 | $12,111 | 41.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 107 | 136 | $11,904 | $5,779 | 48.5% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2023 | 45 | 46 | $34,316 | $5,738 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $11,516 | $5,108 | 44.4% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Facility | 2023 | 14 | 14 | $16,870 | $4,617 | 27.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 37 | 37 | $24,864 | $4,611 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 43 | $8,464 | $4,300 | 50.8% |
| 15220 | Full thickness skin graft to scalp, arms, or legs, 20.0 sq cm or less | Facility | 2023 | 13 | 13 | $15,769 | $3,095 | 19.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 39 | 76 | $6,739 | $2,514 | 37.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 44 | 44 | $4,981 | $2,240 | 45.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Facility | 2023 | 16 | 16 | $10,064 | $2,143 | 21.3% |
About Dr. David Byrd, M.D
Dr. David Byrd, M.D is a MOHS-Micrographic Surgery healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467469197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Byrd, M.D has received a total of $9,566 in payments from pharmaceutical and medical device companies, with $1,984 received in 2024. These payments were reported across 569 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,093).
As a Medicare-enrolled provider, Byrd has provided services to 13,235 Medicare beneficiaries, totaling 27,517 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Rochester Hills, MI
- Active Since 08/02/2006
- Last Updated 02/11/2014
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1467469197
Products in Payments
- DUPIXENT (Biological) $920.90
- TREMFYA (Drug) $684.49
- COSENTYX (Biological) $635.37
- REMICADE (Biological) $468.73
- ADBRY (Biological) $410.84
- RINVOQ (Biological) $397.31
- SKYRIZI (Biological) $373.36
- EUCRISA (Drug) $348.13
- ENSTILAR (Drug) $293.13
- COSENTYX (Drug) $292.05
- TALTZ (Drug) $280.54
- AMZEEQ (Drug) $222.15
- Seysara (Drug) $188.56
- VTAMA (Drug) $187.18
- Cimzia (Drug) $179.56
- Humira (Biological) $162.72
- OPZELURA (Drug) $148.32
- AKLIEF (Drug) $137.13
- EPSOLAY (Drug) $122.32
- AMELUZ (Drug) $117.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.